The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency

Mudi Misgav, Ahron Lubetszki, Tami Brutman-Barazani, Uri Martinowitz, Gili Kenet

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Background: Patients on chronic hemodialysis often have acquired coagulopathy that can aggravate bleeding from puncture site after needle extraction. Chitosan-based pads have been reported to accelerate hemostasis even in the presence of coagulopathy. The aim of this study was to evaluate the hemostatic efficacy of the chitosan pads compared to gauze pads, applied for local hemostasis. Methods: A crossover study in a cohort of patients on hemodialysis with extended time to hemostasis after needle extraction. At the end of each dialysis, either gauze or chitosan pad was applied on both access points (arterial and venous). The type of pad was changed in the next dialysis all together 5 times in each patient (10 applications per patient for every pad). Results: A total of 288 applications, 144 for each type of pad, were performed in 15 patients. The average time to hemostasis for the entire group was significantly shorter with the chitosan pads compared to the regular gauze pads (“arterial” point 3 vs. 18.5 min, p<0.001 “venous” access 2.8 vs. 13.2 min, p<0.001, respectively). Conclusions: Chitosan pads significantly reduce time to hemostasis and should be considered for the treatment of accessible bleeds in patients with coagulopathy.

Original languageEnglish
Pages (from-to)220-224
Number of pages5
JournalJournal of Vascular Access
Issue number3
StatePublished - 15 May 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 Wichtig Publishing.


  • Chitosan-acetate dressing
  • Hemodialysis
  • Hemostasis


Dive into the research topics of 'The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency'. Together they form a unique fingerprint.

Cite this